Bewertung und Feedback des Lernenden für Drug Commercialization von University of California San Diego
Über den Kurs
Top-Bewertungen
Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.
Great contents covering economics, marketing, regulation, IP, academics-industry collaboration, and actual successful biotech startup stories. I highly recommended this course.
126 - 150 von 194 Bewertungen für Drug Commercialization
von Dr. S T
•nice experience
von ALISA C D
•Love the course
von Prasun N
•great learning
von �ADITI P
•...........
von Utku U
•Excellent!
von Sourav M
•Thank you.
von PANDYA Y U
•Excellant
von Afroj K
•Excellent
von Ngân Đ N T
•Love it
von Lokesh
•Amazing
von MRS. S
•Helpful
von NABHAN M H A
•thanks
von Mintu S T
•Cool!!
von Atocha C S
•Great!
von Md. R Q S
•great
von Farhan s
•good
von 19BBT006-ANASWAR S B B B
•Good
von Uma M K
•Good
von Mohammad j s
•good
von Julen D L C
•The course is pretty good and really interesting, but it is too out-of-date. I think that this course would win a lot if actualized. Sometimes, the content should be more accurate, and in order to make it more useful for (future) workers on the pharmaceutical industry, I think this scheme should be followed in all subjects: present a topic --> main keys to follow when working on this area --> practical examples. Thank you!
von Aedrian A
•This is a highly insightful course on the reality (both the highs and lows) of the drug commercialization process. Unfortunately, as of this writing, the material is relatively outdated. I hope the instructors provide a necessary massive updating of the contents as soon as possible.
von Olivia P L M
•Great course that allows me to look somewhat into health economics and other areas such as marketing. It also shows me statistics that can be quite alarming at times. Definitely learnt a lot of interesting terms and built on new knowledge due to this course. Thank you!
von David L
•Nice introduction to drug commercialization. It's a bit out of date though. The examples were current at the time, but new modalities, i.e. mAbs, cell and gene therapies, have rapidly overtaken small molecules as the "hottest" entities for commercialization.
von Abram S
•Holistic view of the commercial side of the industry from many different angles. Excellent and varied speakers with interesting cases. The only negative point is the lack of more current data (ending around 2015).
von Anindita R
•Liked the course and learned some interesting information about the pharma and biotech industry. I would have appreciated more updated information, however, those can be found on the internet with some research.
Coursera Footer
